Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,145 GBX | +3.01% | +3.95% | +9.20% |
10:48am | Deutsche says buy Barr, Britvic and Fevertree | AN |
03-27 | Sainsbury's, Petershill Partners upped to 'buy' | AN |
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 87.35 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 3.32 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Distillers & Wineries
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.20% | 1.63B | C- | ||
-2.68% | 77.17B | A- | ||
-10.95% | 38.43B | C+ | ||
-15.88% | 23.22B | B | ||
-5.71% | 8.78B | B | ||
-8.59% | 5.2B | B- | ||
-21.96% | 4.94B | B | ||
+8.35% | 4.58B | - | ||
+5.96% | 2.84B | C | ||
-17.78% | 1.79B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FEVR Stock
- Ratings Fevertree Drinks PLC